Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.

@article{Pierce2009ElevatedBO,
  title={Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.},
  author={Brandon L Pierce and Rachel Ballard-Barbash and Leslie Bernstein and Richard Baumgartner and Marian L Neuhouser and Kathleen Mullan Harris and Kathy B. Baumgartner and Frank D Gilliland and Bess E Sorensen and Anne Mctiernan and Cornelia M Ulrich},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 21},
  pages={
          3437-44
        }
}
PURPOSE Chronic inflammation is believed to contribute to the development and progression of breast cancer. Systemic C-reactive protein (CRP) and serum amyloid A (SAA) are measures of low-grade chronic inflammation and potential predictors of cancer survival. PATIENTS AND METHODS We evaluated the relationship between circulating markers of inflammation and breast cancer survival using data from the Health, Eating, Activity, and Lifestyle (HEAL) Study (a multiethnic prospective cohort study of… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 330 CITATIONS, ESTIMATED 61% COVERAGE

Serum amyloid A1 is upregulated in human glioblastoma

  • Journal of Neuro-Oncology
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2008
2019

CITATION STATISTICS

  • 22 Highly Influenced Citations

  • Averaged 26 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness.

  • Clinical chemistry and laboratory medicine
  • 1999
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer

AM Al Murri, C Wilson, A Lannigan
  • Br J Cancer 96:891-895,
  • 2007
VIEW 1 EXCERPT

Evaluation of an inflammation - based prognostic score ( GPS ) in patients with metastatic breast can

AM AlMurri, JM Bartlett, PA Canney
  • Br J Cancer
  • 2006

Similar Papers

Loading similar papers…